(Kulu Devlet Hastanesi, Kardiyoloji Bölümü, Konya, Türkiye)
Taner ULUS
(Eskişehir Osmangazi Üniversitesi, Tıp Fakültesi, Kardiyoloji Anabilim Dalı, Eskişehir, Türkiye)
(Eskişehir Osmangazi Üniversitesi, Tıp Fakültesi, Kardiyoloji Anabilim Dalı, Eskişehir, Türkiye)
Yıl: 2020Cilt: 23Sayı: 4ISSN: 2149-2263 / 2149-2271Sayfa Aralığı: 196 - 203İngilizce

12 0
Important tips reflcted in our daily practice from the American College of Cardiology Electrophysiology Council report on premature ventricular contractions
Premature ventricular contractions (PVCs) is one of the most common situations in the current cardiology practice. Although PVCs are generally benign in people without any structural heart disease, they may be associated with left ventricular dysfunction, cardiomyopathy, and, rarely, sudden death. Recently, there has been a considerable research in the pathophysiology of PVC, several clinical presentations in different situations, new proposals of successful diagnostic methods, and treatment modalities. Finally, the American College of Cardiology Electrophysiology Council has published a special report that deals with all the aspects of PVC. We reviewed the important points from this report that can be reflected in our daily practice. (Anatol J Cardiol 2020; 23: 196-203)
DergiDerlemeErişime Açık
  • 1. Gorenek B, Fisher JD, Kudaiberdieva G, Baranchuk A, Burri H, Campbell KB, et al. Premature ventricular complexes: diagnostic and therapeutic considerations in clinical practice : A state-of-theart review by the American College of Cardiology Electrophysiology Council. J Interv Card Electrophysiol 2019 Dec 11. doi: 10.1007/ s10840-019-00655-3. [Epub ahead of print]
  • 2. Bigger J, Dresdale R, Heissenbuttel R, Weld FM, Wit AL. Ventricular arrhythmias in ischemic heart disease: mechanism, prevalence, significance and management. Prog Cardiovasc Dis 1977; 19: 255–300.
  • 3. Moss A, Davis H, DeCamilla J, Bayer LW. Ventricular ectopic beat and their relation to sudden and non-sudden cardiac death after myocardial infarction. Circulation 1979; 60: 998–1003.
  • 4. Ng GA. Treating patients with ventricular ectopic beats. Heart 2006; 92: 1707–12.
  • 5. Kennedy HL, Whitlock JA, Sprague MK, Kennedy LJ, Buckingham TA, Goldberg RJ. Long-term follow-up of asymptomatic healthy subjects with frequent and complex ventricular ectopy. N Engl J Med 1985; 312: 193–7.
  • 6. Cronin EM, Bogun FM, Maury P, Peichl P, Chen M, Namboodiri N, et al. 2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias. J Arrhythm 2019; 35: 323-484.
  • 7. Priori SG, Blomström-Lundqvist C, Mazzanti A, Blom N, Borggrefe M, Camm J, et al.; ESC Scientific Document Group. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Eur Heart J 2015; 36: 2793–867.
  • 8. Latchamsetty R, Bogun F. Premature ventricular complexes and premature ventricular complex induced cardiomyopathy. Curr Probl Cardiol 2015; 40: 379–422.
  • 9. Panizo JG, Barra S, Mellor G, Heck P, Agarwal S. Premature ventricular complex-induced cardiomyopathy. Arrhythm Electrophysiol Rev 2018; 7: 128-34.
  • 10. Bucciarelli-Ducci C, Baritussio A, Auricchio A. Cardiac MRI Anatomy and Function as a Substrate for Arrhythmias. Europace 2016;18 (suppl 4): iv130-5.
  • 11. Wu KC, Weiss RG, Thiemann DR, Kitagawa K, Schmidt A, Dalal D, et al. Late gadolinium enhancement by cardiovascular magnetic resonance heralds an adverse prognosis in nonischemic cardiomyopathy. J Am Coll Cardiol 2008; 51: 2414–21.
  • 12. Disertori M, Rigoni M, Pace N, Casolo G, Masè M, Gonzini L, et al. Myocardial Fibrosis Assessment by LGE Is a Powerful Predictor of Ventricular Tachyarrhythmias in Ischemic and Nonischemic LV Dysfunction: A Meta-Analysis. JACC Cardiovasc Imaging 2016; 9: 1046–55.
  • 13. Indik JH, Gimbel JR, Abe H, Alkmim-Teixeira R, BirgersdotterGreen U, Clarke GD, et al. 2017 HRS expert consensus statement on magnetic resonance imaging and radiation exposure in patients with cardiovascular implantable electronic devices. Heart Rhythm 2017; 14: e97-153.
  • 14. Muthalaly RG, Nerlekar N, Ge Y, Kwong RY, Nasis A. MRI in Patients with Cardiac Implantable Electronic Devices. Radiology 2018; 289: 281-92.
  • 15. Jacobsen JR, Garson A Jr, Gillette PC, McNamara DG. Premature ventricular contractions in normal children. J Pediatr 1978; 92: 36-8.
  • 16. Frolkis JP, Pothier CE, Blackstone EH, Lauer MS. Frequent ventricular ectopy after exercise as a predictor of death. N Engl J Med 2003; 348: 781-90.
  • 17. Dewey FE, Kapoor JR, Williams RS, Lipinski MJ, Ashley EA, Hadley D, et al. Ventricular arrhythmias during clinical treadmill testing and prognosis. Arch Intern Med 2008; 168: 225–34.
  • 18. Kim J, Kwon M, Chang J, Harris D, Gerson MC, Hwang SS, et al. Meta-Analysis of Prognostic Implications of Exercise-Induced Ventricular Premature Complexes in the General Population. Am J Cardiol 2016; 118: 725–32.
  • 19. Al-Khatib SM, Stevenson WG, Ackerman MJ, Bryant WJ, Callans DJ, Curtis AB, et al. 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol 2018; 72: e91-220.
  • 20. de Vries LJ, Martirosyan M, van Domburg RT, Wijchers SA, Géczy T, Szili-Torok T. Coupling interval variability of premature ventricular contractions in patients with different underlying pathology: an insight into the arrhythmia mechanism. J Interv Card Electrophysiol 2018; 51: 25-33.
  • 21. Cantillon DJ. Evaluation and management of premature ventricular complexes. Cleve Clin J Med 2013; 80: 377-87.
  • 22. Lerman BB, Ip JE, Shah BK, Thomas G, Liu CF, Ciaccio EJ, et al. Mechanism-specific effects of adenosine on ventricular tachycardia. J Cardiovasc Electrophysiol 2014; 25: 1350–8.
  • 23. Lee V, Perera D, Lambiase P. Prognostic significance of exercise induced premature ventricular complexes: a systematic review and meta-analysis of observational studies. Heart Asia 2017; 9: 14–24.
  • 24. Biffi A, Pelliccia A, Verdile L, Fernando F, Spataro A, Caselli S, et al. Long-term clinical significance of frequent and complex ventricular tachyarrhythmias in trained athletes. J Am Coll Cardiol 2002; 40: 446–52.
  • 25. Sadron Blaye-Felice M, Hamon D, Sacher F, Pascale P, Rollin A, Duparc A, et al. Premature ventricular contraction-induced cardiomyopathy: related clinical and electrophysiologic parameters. Heart Rhythm 2016; 13: 103–10.
  • 26. Yokokawa M, Kim HM, Good E, Chugh A, Pelosi F Jr, Alguire C, et al. Relation of symptoms and symptom duration to premature ventricular complex-induced cardiomyopathy. Heart Rhythm 2012; 9: 92–5.
  • 27. Olgun H, Yokokawa M, Baman T, Kim HM, Armstrong W, Good E, et al. The role of interpolation in PVC-induced cardiomyopathy. Heart Rhythm 2011; 8: 1046–9.
  • 28. Carballeira Pol L, Deyell MW, Frankel DS, Benhayon D, Squara F, Chik W, et al. Ventricular premature depolarization QRS duration as a new marker of risk for the development of ventricular premature depolarization-induced cardiomyopathy. Heart Rhythm 2014; 11: 299–306.
  • 29. Gaita F, Giustetto C, Di Donna P, Richiardi E, Libero L, Brusin MC, et al. Long-term follow-upofright ventricular monomorphic extrasystoles. J Am Coll Cardiol 2001; 38: 364–70.
  • 30. Panizo JG, Barra S, Mellor G, Heck P, Agarwal S. Premature ventricular complex-induced cardiomyopathy. Arrhythm Electrophysiol Rev 2018; 7: 128-34.
  • 31. Echt DS, Liebson PR, Mitchell LB, Peters RW, Obias-Manno D, Barker AH, et al. Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial. N Engl J Med 1991; 324: 781–8.
  • 32. Waldo AL, Camm AJ. deRuyter H, Friedman PL, MacNeil DJ, Pauls JF, et al. Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. The SWORD Investigators. Survival with Oral d-Sotalol. Lancet 1996; 348: 7–12.
  • 33. Hyman MC, Mustin D, Supple G, Schaller RD, Santangeli P, Arkles J, et al. Class IC antiarrhythmic drugs for suspected premature ventricular contraction-induced cardiomyopathy. Heart Rhythm 2018; 15: 159–63.
  • 34. Sarrazin JF, Labounty T, Kuhne M, Crawford T, Armstrong WF, Desjardins B, et al. Impact of radiofrequency ablation of frequent post-infarction premature ventricular complexes on left ventricular ejection fraction. Heart Rhythm 2009; 6: 1543–9.
  • 35. Mountantonakis SE, Frankel DS, Gerstenfeld EP, Dixit S, Lin D, Hutchinson MD, et al. Reversal of outflow tract ventricular premature depolarization-induced cardiomyopathy with ablation: effect of residual arrhythmia burden and preexisting cardiomyopathy on outcome. Heart Rhythm 2011; 8: 1608–14.
  • 36. Penela D, Van Huls Van Taxis C, Van Huls Vans Taxis C, Aguinaga L, Fernández-Armenta J, Mont L, et al. Neurohormonal, structural, and functional recovery pattern after premature ventricular complex ablation is independent of structural heart disease status in patients with depressed left ventricular ejection fraction: a prospective multicenter study. J Am Coll Cardiol 2013; 62: 1195–202.
  • 37. Friedrich MG, Sechtem U, Schulz-Menger J, Holmvang G, Alakija P, Cooper LT, et al.; International Consensus Group on Cardiovascular Magnetic Resonance in Myocarditis. Cardiovascular magnetic resonance in myocarditis: A JACC White Paper. J Am Coll Cardiol 2009; 53: 1475–87.
  • 38. Strain JE, Grose RM, Factor SM, Fisher JD. Results of endomyocardial biopsy in patients with spontaneous ventricular tachycardia but without apparent structural heart disease. Circulation 1983; 68: 1171–81.
  • 39. Dello Russo A, Casella M, Pieroni M, Pelargonio G, Bartoletti S, Santangeli P, et al. Drug-refractory ventricular tachycardias after myocarditis: endocardial and epicardial radiofrequency catheter ablation. Circ Arrhythmia Electrophysiol 2012; 5: 492–8.
  • 40. Sarrazin JF, Good E, Kuhne M, Oral H, Pelosi F Jr, Chugh A, et al. Mapping and ablation of frequent post-infarction premature ventricular complexes. J Cardiovasc Electrophysiol 2010; 21: 1002–8.
  • 41. Sramko M, Hoogendoorn JC, Glashan CA, Zeppenfeld K. Advancement in cardiac imaging for treatment of ventricular arrhythmias in structural heart disease. Europace 2019; 21: 383-403.
  • 42. Cullen S, Celermajer DS, Franklin RCG, Hallidie-Smith KA, Deanfield JE. Prognostic significance of ventricular arrhythmia after repair of tetralogy of Fallot: a 12-year prospective study. J Am Coll Cardiol 1994; 23: 1151–5.
  • 43. Spartalis M, Tzatzaki E, Spartalis E, Athanasiou A, Moris D, Damaskos C, et al. Mitral valve prolapse: an underestimated cause of sudden cardiac death-a current review of the literature. J Thorac Dis 2017; 9: 5390–8.
  • 44. DeBacker G, Jacobs D, Prineas R, Crow R, Vilandre J, Kennedy H, et al. Ventricular premature contractions: a randomized nondrug intervention trial in normal men. Circulation 1979; 59: 762–9.
  • 45. Krittayaphong R, Bhuripanyo K, Punlee K, Kangkagate C, Chaithiraphan S. Effect of atenolol on symptomatic ventricular arrhythmia without structural heart disease: a randomized placebo-controlled study. Am Heart J 2002; 144: e10.
  • 46. Capucci A, Di Pasquale G, Boriani G, Carini G, Balducelli M, Frabetti L, et al. A double-blind crossover comparison of flecainide and slow-release mexiletine in the treatment of stable premature ventricular complexes. Int J Clin Pharmacol Res 1991; 11: 23–33.
  • 47. Stec S, Sikoraks A, Zaborska B, Kryński T, Szymot J, Kułakowski P. Benign symptomatic premature ventricular complexes: shortand long-term efficacy of antiarrhythmic drugs and radiofrequency ablation. Kardiol Pol 2012; 70: 351–8.
  • 48. Cardiac Arrhythmia Suppression Trial II Investigators. Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction. N Engl J Med 1992; 327: 227–33.
  • 49. Hohnloser SH, Zabel M, Krause T, Just H. Short- and long-term antiarrhythmic and hemodynamic effects of d,l-sotalol in patients with symptomatic ventricular arrhythmias. Am Heart J 1992; 123: 1220–4.
  • 50. Singh SN, Fletcher RD, Fisher SG, Singh BN, Lewis HD, Deedwania PC, et al. Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure. N Engl J Med 1995; 333: 77–82.
  • 51. Ling Z, Liu Z, Su L, Zipunnikov V, Wu J, Du H, et al. Radiofrequency ablation versus antiarrhythmic medication for treatment of ventricular premature beats from the right ventricular outflow tract: prospective randomized study. Circ Arrhythm Electrophysiol 2014; 7: 237–43.
  • 52. Baman TS, Ilg KJ, Gupta SK, Good E, Chugh A, Jongnarangsin K, et al. Mapping and ablation of epicardial idiopathic ventricular arrhythmias from within the coronary venous system. Circ Arrhythm Electrophysiol 2010; 3: 274–9.
  • 53. Yamada T, McElderry HT, Doppalapudi H, Okada T, Murakami Y, Yoshida Y, et al. Idiopathic ventricular arrhythmias originating from the left ventricular summit: anatomic concepts relevant to ablation. Circ Arrhythm Electrophysiol 2010; 3: 616–23.
  • 54. Fisher JD. Hemiblocks and the fascicular system: myths and implications. J Interv Card Electrophysiol 2018; 52: 281–5.
  • 55. Koruth JS, Dukkipati S, Miller MA, Neuzil P, d’Avila A, Reddy VY. Bipolar irrigated radiofrequency ablation: a therapeutic option for refractory intramural atrial and ventricular tachycardia circuits. Heart Rhythm 2012; 9: 1932–41.

TÜBİTAK ULAKBİM Ulusal Akademik Ağ ve Bilgi Merkezi Cahit Arf Bilgi Merkezi © 2019 Tüm Hakları Saklıdır.